Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Heart and Vessels
Published in: Heart and Vessels 9/2023

09-01-2023 | Letter

Author’s reply: Efficacy of a phosphodiesterase type 5 inhibitor on the pulmonary artery index and postoperative hemodynamics after a Fontan operation

Authors: Takuro Kojima, Koichi Toda, Taisuke Nabeshima, Shigeki Yoshiba, Toshiki Kobayashi, Naokata Sumitomo

Published in: Heart and Vessels | Issue 9/2023

Login to get access

Excerpt

We would like to thank you for the opportunity to respond Dr. Ibuki’s letter, which clarifies issues regarding our manuscript. …
Literature
1.
Kojima T, Toda K, Nabeshima T, Yoshiba S, Kobayashi T, Sumitomo N (2022) Efficacy of a phosphodiesterase type 5 inhibitor on the pulmonary artery index and postoperative hemodynamics after a Fontan operation. Heart Vessels 37:1921–1927CrossRefPubMed
Metadata
Title
Author’s reply: Efficacy of a phosphodiesterase type 5 inhibitor on the pulmonary artery index and postoperative hemodynamics after a Fontan operation
Authors
Takuro Kojima
Koichi Toda
Taisuke Nabeshima
Shigeki Yoshiba
Toshiki Kobayashi
Naokata Sumitomo
Publication date
09-01-2023
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 9/2023
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-022-02227-4

Other articles of this Issue 9/2023

Heart and Vessels 9/2023 Go to the issue

Original Article

MELD-score for risk stratification in cardiac surgery

Original Article

Multicenter, retrospective registry of isolated atherosclerotic popliteal arteries treated with endovascular revascularization

Original Article

Impact of minimum contrast media volumes during percutaneous coronary intervention for chronic total occlusion lesion

Original Article

Age and sex differences in the risk of cardiovascular diseases by chronic kidney disease in a general Japanese population

Letter

Clinical implication of trend of pulmonary artery index following Fontan operation

Original Article

Progression from paroxysmal to persistent atrial fibrillation in pacemaker patients with tachycardia–bradycardia syndrome: a multicenter study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits